Hims & Hers Health Inc [HIMS] stock prices are up 7.65% to $37.41 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The HIMS shares have gain 7.84% over the last week, with a monthly amount drifted -24.09%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on February 18, 2025, when Morgan Stanley downgraded its rating to a Equal-Weight and also boosted its price target to $60 from $42. Previously, Citigroup downgraded its rating to Sell on January 10, 2025, and elevated its price target to $25. On January 07, 2025, BTIG Research initiated with a Buy rating and assigned a price target of $35 on the stock. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $42 on December 17, 2024. BofA Securities downgraded its rating to a Underperform. Needham started tracking with a Buy rating for this stock on August 22, 2024, and assigned it a price target of $24. In a note dated August 09, 2024, Imperial Capital downgraded an In-line rating on this stock.
The stock price of Hims & Hers Health Inc [HIMS] has been fluctuating between $11.20 and $72.98 over the past year. Currently, Wall Street analysts expect the stock to reach $31.83 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $37.41 at the most recent close of the market. An investor can expect a potential drop of -14.92% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
The Hims & Hers Health Inc [NYSE:HIMS] reported sales of 1.48B for trailing twelve months, representing a surge of 95.09%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.18, Equity is 0.31 and Total Capital is 0.13. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 35.49 points at the first support level, and at 33.58 for the second support level. However, for the 1st resistance point, the stock is sitting at 38.75, and for the 2nd resistance point, it is at 40.10.
Ratios To Look Out For
It’s worth pointing out that Hims & Hers Health Inc [NYSE:HIMS]’s Current Ratio is 1.79. On the other hand, the Quick Ratio is 1.50, and the Cash Ratio is 1.0. Considering the valuation of this stock, the price to sales ratio is 5.63, the price to book ratio is 17.33 and price to earnings (TTM) ratio is 69.95.
Transactions by insiders
Recent insider trading involved Okupe Oluyemi, Chief Financial Officer, that happened on Mar 21 ’25 when 23118.0 shares were sold. Officer, Oluyemi Okupe completed a deal on Mar 21 ’25 to buy 69442.0 shares. Meanwhile, Chief Medical Officer Carroll Patrick Harrison sold 23287.0 shares on Mar 18 ’25.
